Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
1.380
-0.185 (-11.82%)
At close: May 15, 2025, 4:00 PM
1.400
+0.020 (1.45%)
After-hours: May 15, 2025, 5:36 PM EDT
Mangoceuticals Employees
Mangoceuticals had 3 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$205,291
Profits / Employee
-$3,192,807
Market Cap
8.62M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MGRX News
- 17 days ago - ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market - Newsfile Corp
- 19 days ago - CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector - Newsfile Corp
- 20 days ago - ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector - Newsfile Corp
- 20 days ago - Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division - GlobeNewsWire
- 23 days ago - CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape - Accesswire
- 3 months ago - Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation - GlobeNewsWire
- 5 months ago - Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent - GlobeNewsWire
- 7 months ago - MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly - GlobeNewsWire